D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 96 Citations 32,944 277 World Ranking 111 National Ranking 55
Medicine D-index 83 Citations 39,386 254 World Ranking 8173 National Ranking 4453

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Bacteria
  • Antibiotics

His primary scientific interests are in Microbiology, Staphylococcus aureus, Endocarditis, Daptomycin and Infective endocarditis. His Microbiology research incorporates themes from In vitro, Mutant, Cell membrane, Membrane fluidity and Teichoic acid. The various areas that Arnold S. Bayer examines in his Staphylococcus aureus study include Antibacterial agent, In vivo and Virulence.

His Daptomycin research integrates issues from Lipopeptide, Polymyxin B and Drug resistance. Arnold S. Bayer has researched Infective endocarditis in several fields, including Disease, Cohort, Pathogenesis and Intensive care medicine. His work carried out in the field of Methicillin-resistant Staphylococcus aureus brings together such families of science as Bacteremia and Immunology.

His most cited work include:

  • Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children (2524 citations)
  • Infective Endocarditis Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America (1507 citations)
  • Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study (1271 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Microbiology, Staphylococcus aureus, Endocarditis, Antibiotics and Methicillin-resistant Staphylococcus aureus. His studies in Microbiology integrate themes in fields like In vitro, Vancomycin, Daptomycin, In vivo and Virulence. His Staphylococcus aureus research is mostly focused on the topic Staphylococcal infections.

His Endocarditis research focuses on Infective endocarditis and how it relates to Disease. His Antibiotics course of study focuses on Antimicrobial and Peptide. His research integrates issues of Phenotype, Cefazolin, Genotype and Biofilm in his study of Methicillin-resistant Staphylococcus aureus.

He most often published in these fields:

  • Microbiology (101.02%)
  • Staphylococcus aureus (86.27%)
  • Endocarditis (41.19%)

What were the highlights of his more recent work (between 2016-2021)?

  • Microbiology (101.02%)
  • Staphylococcus aureus (86.27%)
  • Daptomycin (36.07%)

In recent papers he was focusing on the following fields of study:

Arnold S. Bayer mainly investigates Microbiology, Staphylococcus aureus, Daptomycin, Methicillin-resistant Staphylococcus aureus and Antibiotics. His Microbiology study combines topics in areas such as Infective endocarditis, In vitro, Endocarditis, Vancomycin and Genotype. The Staphylococcus aureus study combines topics in areas such as Bacteremia and Gene, Virulence.

His Daptomycin research is multidisciplinary, relying on both Enzyme, Streptococcus mitis, Antibiotic resistance, Lipopeptide and In vivo. His research on Methicillin-resistant Staphylococcus aureus also deals with topics like

  • Lysin together with Pharmacology,
  • Beta most often made with reference to Bicarbonate. His work is dedicated to discovering how Antibiotics, Staphylococcal infections are connected with Adjunctive treatment and other disciplines.

Between 2016 and 2021, his most popular works were:

  • Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance (30 citations)
  • Gain-of-Function Mutations in the Phospholipid Flippase MprF Confer Specific Daptomycin Resistance (30 citations)
  • Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism (27 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Bacteria
  • Antibiotics

His scientific interests lie mostly in Microbiology, Staphylococcus aureus, Daptomycin, Methicillin-resistant Staphylococcus aureus and Antibiotics. The study incorporates disciplines such as Point mutation and Gene, Genotype in addition to Microbiology. His Daptomycin research includes elements of Streptococcus mitis, Lipopeptide and In vitro.

The concepts of his Antibiotics study are interwoven with issues in Staphylococcal infections, Antiseptic, Vancomycin and Mupirocin. Arnold S. Bayer interconnects Infective endocarditis, Cefazolin and Penicillin binding proteins in the investigation of issues within Antimicrobial. His Infective endocarditis study deals with MEDLINE intersecting with Endocarditis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Catherine Liu;Arnold Bayer;Sara E. Cosgrove;Robert S. Daum.
Clinical Infectious Diseases (2011)

4042 Citations

Infective Endocarditis Diagnosis, Antimicrobial Therapy, and Management of Complications: A Statement for Healthcare Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: Endorsed by the Infectious Diseases Society of America

Larry M. Baddour;Walter R. Wilson;Arnold S. Bayer;Vance G. Fowler.
Circulation (2005)

2409 Citations

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications A Scientific Statement for Healthcare Professionals From the American Heart Association

Larry M. Baddour;Walter R. Wilson;Arnold S. Bayer;Vance G. Fowler.
Circulation (2015)

1908 Citations

Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis-Prospective Cohort Study

David R. Murdoch;G. Ralph Corey;Bruno Hoen;José M. Miró.
JAMA Internal Medicine (2009)

1706 Citations

Necrotizing Fasciitis Caused by Community-Associated Methicillin-Resistant Staphylococcus aureus in Los Angeles

Loren G. Miller;Francoise Perdreau-Remington;Gunter Rieg;Sheherbano Mehdi.
The New England Journal of Medicine (2005)

1396 Citations

Staphylococcus aureus Endocarditis A Consequence of Medical Progress

Vance G. Fowler;Jose M. Miro;Bruno Hoen;Christopher H. Cabell.
JAMA (2005)

1165 Citations

Diagnosis and Management of Infective Endocarditis and Its Complications

Arnold S. Bayer;Ann F. Bolger;Kathryn A. Taubert;Walter Wilson.
Circulation (1998)

949 Citations

Prevention of Bacterial Endocarditis: Recommendations by the American Heart Association

Adnan S. Dajani;Kathryn A. Taubert;Walter Wilson;Ann F. Bolger.
Survey of Anesthesiology (1998)

905 Citations

Prevention of bacterial endocarditis

Adrian S. Dajani;Kathryn A. Taubert;Walter Wilson;Ann F. Bolger.
JAMA (1997)

845 Citations

Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus

Ambrose L Cheung;Arnold S Bayer;Arnold S Bayer;Gongyi Zhang;Hattie Gresham.
Fems Immunology and Medical Microbiology (2004)

542 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Arnold S. Bayer

Michael J. Rybak

Michael J. Rybak

Eugene Applebaum College of Pharmacy and Health Sciences

Publications: 201

Vance G. Fowler

Vance G. Fowler

Duke University

Publications: 137

George Sakoulas

George Sakoulas

University of California, San Diego

Publications: 114

Cesar A. Arias

Cesar A. Arias

The University of Texas Health Science Center at Houston

Publications: 101

José M. Miró

José M. Miró

University of Barcelona

Publications: 97

Victor Nizet

Victor Nizet

University of California, San Diego

Publications: 89

Larry M. Baddour

Larry M. Baddour

Mayo Clinic

Publications: 88

G. Ralph Corey

G. Ralph Corey

Duke University

Publications: 77

Gilbert Habib

Gilbert Habib

Hôpital de la Timone

Publications: 73

Michael Otto

Michael Otto

National Institutes of Health

Publications: 73

Walter R. Wilson

Walter R. Wilson

Mayo Clinic

Publications: 68

Michael R. Yeaman

Michael R. Yeaman

University of California, Los Angeles

Publications: 65

Patricia Muñoz

Patricia Muñoz

Hospital General Universitario Gregorio Marañón

Publications: 54

Georg Peters

Georg Peters

University of Münster

Publications: 54

Paul M. Sullam

Paul M. Sullam

University of California, San Francisco

Publications: 51

Richard A. Proctor

Richard A. Proctor

University of Wisconsin–Madison

Publications: 51

Something went wrong. Please try again later.